Preserved ophthalmic compositions

Details for Australian Patent Application No. 2004226466 (hide)

Owner Allergan, Inc.

Inventors Olejnik, Orest; Huth, Stanley W.; Graham, Richard; Luu, Michelle; Chang, James N.

Agent Davies Collison Cave

Pub. Number AU-B-2004226466

PCT Pub. Number WO2004/087098

Priority 10/400,893 27.03.03 US

Filing date 23 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 22 January 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 33/14 (2006.01) Medicinal preparations containing inorganic active ingredients - Alkali metal chlorides

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087098 Priority application(s): WO2004/087098

22 January 2009 Application Accepted

  Published as AU-B-2004226466

21 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226467-Reduction of hair growth

2004226464-Implant delivery technologies